Growing community of inventors

Bellaterra, Spain

Eduard Ayuso

Average Co-Inventor Count = 9.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Eduard AyusoFátima Bosch Tubert (6 patents)Eduard AyusoMaria Bobadilla (1 patent)Eduard AyusoMaria Antonia Blasco Marhuenda (1 patent)Eduard AyusoIvan Formentini (1 patent)Eduard AyusoFàtima Bosch I Tubert (1 patent)Eduard AyusoChristian Baer (1 patent)Eduard AyusoRosa María Serrano Ruiz (1 patent)Eduard AyusoJacques Mizrahi (1 patent)Eduard AyusoBruno Bernardes De Jesus (1 patent)Eduard AyusoIvan Formentini (0 patent)Eduard AyusoChristian Baer (0 patent)Eduard AyusoBruno Bernardes De Jesus (0 patent)Eduard AyusoMaría Antonia Blasco Marhuenda (0 patent)Eduard AyusoBruno Bernardes (0 patent)Eduard AyusoEduard Ayuso (1 patent)Fátima Bosch TubertFátima Bosch Tubert (6 patents)Maria BobadillaMaria Bobadilla (3 patents)Maria Antonia Blasco MarhuendaMaria Antonia Blasco Marhuenda (3 patents)Ivan FormentiniIvan Formentini (3 patents)Fàtima Bosch I TubertFàtima Bosch I Tubert (2 patents)Christian BaerChristian Baer (2 patents)Rosa María Serrano RuizRosa María Serrano Ruiz (1 patent)Jacques MizrahiJacques Mizrahi (1 patent)Bruno Bernardes De JesusBruno Bernardes De Jesus (1 patent)Ivan FormentiniIvan Formentini (0 patent)Christian BaerChristian Baer (0 patent)Bruno Bernardes De JesusBruno Bernardes De Jesus (0 patent)María Antonia Blasco MarhuendaMaría Antonia Blasco Marhuenda (0 patent)Bruno BernardesBruno Bernardes (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Universität Autonoma De Barcelona (1 from 45 patents)

2. Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncologicas Carlos III (f.s.p. Cnio) (1 from 4 patents)

3. Fundacion Centro Nacional De Investigaciones Oncologicas Carlos III (6 patents)


1 patent:

1. 11261434 - Telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarction

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…